13
April 2021
Alphamab Oncology Presented Clinical Data of KN046 Combined with Nab-paclitaxel in the Treatment of mTNBC at AACR 2021
The results showed that KN046 plus nab-paclitaxel is well tolerated and efficacious, especially in PD-L1-positive mTNBC patients, showing potentially clinically meaningful benefits in progression-free...